The Public Cannabis Company Revenue Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than $2.5 million per quarter (in USD). This data-driven, fact-based tracker will continually update based on new filings so that readers can stay up to date. Companies must file with the SEC or SEDAR to be considered for inclusion.

Fifteen companies currently qualify for inclusion, with six filing in U.S dollars and nine in the Canadian currency.  Two Canadian licensed producers reported financials this week, including CanniMed Therapeutics (TSX: CMED) (OTC: CMMDF) and CannTrust (TSX: TRST) (OTC: CNTTF), which have been  updated to reflect the results:

CanniMed, which reported its last quarter as a public company following its acquisition by Aurora Cannabis (TSX: ACB) (OTC: ACBFF), saw FY18-Q1 sales growth slow to 41% from a year ago, with sales of C$4.82 million matching the sales in the prior quarter. CannTrust, which had previously pre-announced its Q4 sales, reported sales growth of 233%, with the C$6.98 million 13.7% higher than Q3 levels. Oils continued to provide more than half of the revenue. While the company reported positive net income due to fair value changes in biological assets, it generated an EBITDA loss of C$1.67 million.

In the United States, three companies recently reported quarterly sales, including CV Sciences (OTC: CVSI), Grow Generation (OTC: GRWG) and Terra Tech (OTC: TRTC):

CV Sciences posted record sales of $7.24 million in Q4, growing 126% from year-ago levels. The company, which now has its CBD products in 1548 retail stores, reported a gross margin of 72% during the quarter and 70% for the full year. GrowGeneration sales of $3.64 million grew 54% from year ago levels, and the company reaffirmed guidance for $37 million sales in 2018. The company indicated that the fires in Northern California in October had a negative impact on its operations. Terra Tech reported overall sales of $11.01 million, with its cannabis operations in California and Nevada generating $9.42 million, a gain of 108% from a year ago.

In April, several companies will provide updates. Aphria (TSX: APH) (OTC: APHQF) will be reporting its FY18-Q3 results before mid-April. Golden Leaf Holdings (CSE: GLH) (OTC: GLDFF) will be reporting its Q4 financials before the end of the month.  Kush Bottles (OTC: KSHB) has scheduled a call for April 11th to discuss is FY18-Q2 results. Namaste Technologies (CSE: N) (OTC: NXTTF) will report its FY18-Q2 financials by the end of the month. Based on analyst estimates, Organigram (TSXV: OGI) (OTC: OGRMF), which reports its FY18-Q2 by the end of the month, is likely to join the list.

Visit the Public Cannabis Company Revenue Tracker to see the complete list of qualifying companies.

Exclusive article by Alan Brochstein, CFA

Based in Houston, Alan leverages his experience as founder of online community 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email